Fast Disintegrating Combination Tablet of Taste Masked Levocetrizine Dihydrochloride and Montelukast Sodium: Formulation Design, Development, and Characterization

Table 11

Postcompression evaluation of developed formulations.

Formulation	Postcompression evaluation parameters
	Thickness (mm)	Diameter (mm)	Hardness (Kg/cm^2)	Wt. variation	Friability
K1	3.12 ± 0.17	3.0 ± 0.38	3.1 ± 0.68	219.03 ± 1.08	0.49 ± 0.082
K2	3.13 ± 0.14	3.0 ± 0.27	3.2 ± 0.73	218.59 ± 0.94	0.52 ± 0.068
K3	3.12 ± 0.19	3.1 ± 0.28	3.4 ± 0.69	219.13 ± 1.11	0.57 ± 0.072
K4	3.11 ± 0.13	3.0 ± 0.24	3.2 ± 0.47	219.44 ± 0.92	0.47 ± 0.069
K5	3.13 ± 0.11	3.0 ± 0.33	3.3 ± 0.81	220.19 ± 0.91	0.53 ± 0.036
K6	3.12 ± 0.17	3.0 ± 0.36	3.0 ± 0.71	218.31 ± 0.89	0.37 ± 0.074